TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Epidemiology of Atopic Dermatitis, Associated Comorbidities, and Treatment Patterns in the United Kingdom (UK)
Brief Summary: Atopic dermatitis, commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used.

Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently. This study aims to provide accurate estimates of the number of people with current eczema (prevalence), number developing new onset eczema (incidence), and the pattern of common comorbidities in people with eczema. It also aims describe current treatment patterns by age groups and other factors. It also will look back over the last decade to identify how the number of people with eczema and treatments changing over time. The study will also explore patterns in the people most commonly affected and in the treatments used.


Options:
A: Arm Label: 0.3% OPA-15406; Type: EXPERIMENTAL; Interventions: Drug: 0.3% OPA-15406 | Arm Label: 1% OPA-15406; Type: EXPERIMENTAL; Interventions: Drug: 1% OPA-15406 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebos | Intervention Type: DRUG; Name: 0.3% OPA-15406; Assigned to Arm(s): 0.3% OPA-15406 | Intervention Type: DRUG; Name: 1% OPA-15406; Assigned to Arm(s): 1% OPA-15406 | Intervention Type: DRUG; Name: Placebos; Assigned to Arm(s): Placebo
B: Arm Label: Prevalent case of atopic dermatitis; Type: N/A; Interventions: Other: No intervention | Arm Label: Controls; Type: N/A; Interventions: Other: No intervention | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Controls, Prevalent case of atopic dermatitis
C: Arm Label: Crisaborole ointment 2% once daily (QD) vs vehicle QD; Type: EXPERIMENTAL; Interventions: Drug: Crisaborole ointment 2%, Drug: Vehicle | Arm Label: Crisaborole ointment 2% twice daily (BID) vs vehicle BID; Type: EXPERIMENTAL; Interventions: Drug: Crisaborole ointment 2%, Drug: Vehicle | Intervention Type: DRUG; Name: Crisaborole ointment 2%; Assigned to Arm(s): Crisaborole ointment 2% twice daily (BID) vs vehicle BID | Intervention Type: DRUG; Name: Vehicle; Assigned to Arm(s): Crisaborole ointment 2% twice daily (BID) vs vehicle BID | Intervention Type: DRUG; Name: Crisaborole ointment 2%; Assigned to Arm(s): Crisaborole ointment 2% once daily (QD) vs vehicle QD | Intervention Type: DRUG; Name: Vehicle; Assigned to Arm(s): Crisaborole ointment 2% once daily (QD) vs vehicle QD
D: Arm Label: 1. Protopic Exposure; Type: N/A; Interventions: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Epidemiology of Atopic Dermatitis, Associated Comorbidities, and Treatment Patterns in the United Kingdom (UK)
Brief Summary: Atopic dermatitis, commonly called eczema, is one of the most frequently occurring skin conditions. It is estimated to affect around one fifth of children in developed countries and is also becoming increasingly common in less developed countries. Exact estimates of how common eczema is, vary considerably and there has not been an in-depth analysis of the number of people with eczema in the UK. It is also unclear which groups of people are most affected and which treatment options are being used.

Most people with eczema are managed by their general practitioner (GP) with only a few people requiring specialist care. GP records therefore provide an excellent opportunity to explore how common eczema is and which treatments are being used currently. This study aims to provide accurate estimates of the number of people with current eczema (prevalence), number developing new onset eczema (incidence), and the pattern of common comorbidities in people with eczema. It also aims describe current treatment patterns by age groups and other factors. It also will look back over the last decade to identify how the number of people with eczema and treatments changing over time. The study will also explore patterns in the people most commonly affected and in the treatments used.


Options:
A: Arm Label: Cholecalciferol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cholecalciferol | Arm Label: Placebo of cholecalciferol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of cholecalciferol | Intervention Type: DRUG; Name: Cholecalciferol; Assigned to Arm(s): Cholecalciferol | Intervention Type: DRUG; Name: Placebo of cholecalciferol; Assigned to Arm(s): Placebo of cholecalciferol
B: Arm Label: Domestic ion-exchange water softener; Type: EXPERIMENTAL; Interventions: Device: Domestic ion-exchange water softener | Arm Label: Usual hard water supply; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Domestic ion-exchange water softener; Assigned to Arm(s): Domestic ion-exchange water softener
C: Arm Label: A: UVA1; Type: EXPERIMENTAL; Interventions: Procedure: UVA1 phototherapy | Arm Label: B: NB UVB; Type: EXPERIMENTAL; Interventions: Procedure: NB-UVB phototherapy | Intervention Type: PROCEDURE; Name: UVA1 phototherapy; Assigned to Arm(s): A: UVA1 | Intervention Type: PROCEDURE; Name: NB-UVB phototherapy; Assigned to Arm(s): B: NB UVB
D: Arm Label: Prevalent case of atopic dermatitis; Type: N/A; Interventions: Other: No intervention | Arm Label: Controls; Type: N/A; Interventions: Other: No intervention | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Controls, Prevalent case of atopic dermatitis

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: To Study and Evaluate the Effectiveness of Treatment by Percutaneous Electrical NeuroStimulation (PENS) for Post-operative Pain in Cesarean Section Patients Using Primary Relief v 2.0
Brief Summary: To study and evaluate the Effectiveness of Treatment by Percutaneous Electrical NeuroStimulation (PENS) for post-operative pain in Cesarean Section patients using First Relief


Options:
A: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Battlefield Auricular Acupuncture; Type: EXPERIMENTAL; Interventions: Device: Battlefield Auricular Acupuncture | Intervention Type: DEVICE; Name: Battlefield Auricular Acupuncture; Assigned to Arm(s): Battlefield Auricular Acupuncture
B: Arm Label: Primary Relief v 2.0 Device; Type: EXPERIMENTAL; Interventions: Device: Primary Relief v 2.0 | Arm Label: Paracetamol; Type: PLACEBO_COMPARATOR; Interventions: Drug: Paracetamol | Intervention Type: DEVICE; Name: Primary Relief v 2.0; Assigned to Arm(s): Primary Relief v 2.0 Device | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol
C: Arm Label: Narcotic counseling script; Type: EXPERIMENTAL; Interventions: Behavioral: Narcotic counseling script | Arm Label: Post-partum depression counseling script; Type: SHAM_COMPARATOR; Interventions: Behavioral: Post-partum depression counseling script | Intervention Type: BEHAVIORAL; Name: Narcotic counseling script; Assigned to Arm(s): Narcotic counseling script | Intervention Type: BEHAVIORAL; Name: Post-partum depression counseling script; Assigned to Arm(s): Post-partum depression counseling script
D: Arm Label: Active Group; Type: ACTIVE_COMPARATOR; Interventions: Device: RecoveryRx | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Device: Sham RecoveryRx | Intervention Type: DEVICE; Name: RecoveryRx; Assigned to Arm(s): Active Group | Intervention Type: DEVICE; Name: Sham RecoveryRx; Assigned to Arm(s): Control Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Shared Decision Making to Improve Goals-of-Care Decisions for Families of Severe Acute Brain Injury Patients
Brief Summary: Severe acute brain injury (SABI), including large artery acute ischemic stroke, intracerebral hemorrhage, and severe traumatic brain injury continue to be the leading cause of death and disability in adults in the U.S. Due to concerns for a poor long-term quality of life, withdrawal of mechanical ventilation and supportive medical care with transition to comfort care is the most common cause of death in SABI, but occurs at a highly variable rate (for example in Traumatic Brain Injury (TBI) 45-89%). Decision aids (DAs) are shared decision-making tools which have been successfully implemented and validated for many other diseases to assist difficult decision making. The investigators have developed a pilot DA for goals-of-care decisions for surrogates of SABI patients. This was developed through qualitative research using semi-structured interviews in surrogate decision makers of TBI patients and physicians. The investigators now propose to pilot-test a DA for surrogates of SABI patients in a feasibility trial.


Options:
A: Arm Label: Computerized Decision Support System (CDSS); Type: EXPERIMENTAL; Interventions: Other: Computerized Decision Support System | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Computerized Decision Support System; Assigned to Arm(s): Computerized Decision Support System (CDSS)
B: Arm Label: Feedback Group; Type: EXPERIMENTAL; Interventions: Behavioral: Communication Feedback Form for Patients with Serious Illness | Arm Label: Comparison/Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication Feedback Form for Patients with Serious Illness; Assigned to Arm(s): Feedback Group
C: Arm Label: Usual Care (n=20); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Decision Aid (n=20); Type: EXPERIMENTAL; Interventions: Other: Decision Aid | Intervention Type: OTHER; Name: Decision Aid; Assigned to Arm(s): Decision Aid (n=20)
D: Arm Label: Standard Resource Sheet; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Standard Resource Sheet | Arm Label: Electronic Patient Decision Aid; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Electronic Patient Decision Aid, Behavioral: Standard Resource Sheet | Intervention Type: BEHAVIORAL; Name: Electronic Patient Decision Aid; Assigned to Arm(s): Electronic Patient Decision Aid | Intervention Type: BEHAVIORAL; Name: Standard Resource Sheet; Assigned to Arm(s): Electronic Patient Decision Aid, Standard Resource Sheet

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prediction and Outcome Study in PTSD and (Borderline) Personality Disorders
Brief Summary: The goal of PROSPER-B is to study effectiveness of EMDR compared to integrated DBT-EMDR in treatment-seeking, adult patients with comorbid PTSD and Borderline Personality Disorder (BPD).


Options:
A: Arm Label: PTSD-EMDR; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: EMDR | Arm Label: Integrated DBT-EMDR; Type: EXPERIMENTAL; Interventions: Behavioral: EMDR, Behavioral: DBT | Intervention Type: BEHAVIORAL; Name: EMDR; Assigned to Arm(s): Integrated DBT-EMDR, PTSD-EMDR | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Integrated DBT-EMDR
B: Arm Label: Brief Admission; Type: EXPERIMENTAL; Interventions: Other: Brief Admission | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Brief Admission; Assigned to Arm(s): Brief Admission
C: Arm Label: Psychosocial group intervention; Type: EXPERIMENTAL; Interventions: Behavioral: 10 weekly group meetings, Behavioral: Outpatient counseling and support groups | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Outpatient counseling and support groups | Intervention Type: BEHAVIORAL; Name: 10 weekly group meetings; Assigned to Arm(s): Psychosocial group intervention | Intervention Type: BEHAVIORAL; Name: Outpatient counseling and support groups; Assigned to Arm(s): Control, Psychosocial group intervention
D: Arm Label: SAFE VET; Type: N/A; Interventions: Behavioral: SAFE VET | Arm Label: E-CARE; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SAFE VET; Assigned to Arm(s): SAFE VET

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prediction and Outcome Study in PTSD and (Borderline) Personality Disorders
Brief Summary: The goal of PROSPER-B is to study effectiveness of EMDR compared to integrated DBT-EMDR in treatment-seeking, adult patients with comorbid PTSD and Borderline Personality Disorder (BPD).


Options:
A: Arm Label: App-Condition; Type: EXPERIMENTAL; Interventions: Device: Monsenso DBT-app and IT monitoring program | Arm Label: Paperdiary-condition; Type: ACTIVE_COMPARATOR; Interventions: Other: Paper diary sheet | Intervention Type: OTHER; Name: Paper diary sheet; Assigned to Arm(s): Paperdiary-condition | Intervention Type: DEVICE; Name: Monsenso DBT-app and IT monitoring program; Assigned to Arm(s): App-Condition
B: Arm Label: Priovi; Type: EXPERIMENTAL; Interventions: Behavioral: Priovi, Other: CAU | Arm Label: Care-as-Usual (CAU) / wait list; Type: ACTIVE_COMPARATOR; Interventions: Other: CAU | Intervention Type: BEHAVIORAL; Name: Priovi; Assigned to Arm(s): Priovi | Intervention Type: OTHER; Name: CAU; Assigned to Arm(s): Care-as-Usual (CAU) / wait list, Priovi
C: Arm Label: Inpatient Adaptation of DBT; Type: EXPERIMENTAL; Interventions: Behavioral: Inpatient Adaptation of DBT | Arm Label: Outpatient DBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: standard outpatient DBT | Intervention Type: BEHAVIORAL; Name: standard outpatient DBT; Assigned to Arm(s): Outpatient DBT | Intervention Type: BEHAVIORAL; Name: Inpatient Adaptation of DBT; Assigned to Arm(s): Inpatient Adaptation of DBT
D: Arm Label: PTSD-EMDR; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: EMDR | Arm Label: Integrated DBT-EMDR; Type: EXPERIMENTAL; Interventions: Behavioral: EMDR, Behavioral: DBT | Intervention Type: BEHAVIORAL; Name: EMDR; Assigned to Arm(s): Integrated DBT-EMDR, PTSD-EMDR | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Integrated DBT-EMDR

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prediction and Outcome Study in PTSD and (Borderline) Personality Disorders
Brief Summary: The goal of PROSPER-B is to study effectiveness of EMDR compared to integrated DBT-EMDR in treatment-seeking, adult patients with comorbid PTSD and Borderline Personality Disorder (BPD).


Options:
A: Arm Label: PTSD-EMDR; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: EMDR | Arm Label: Integrated DBT-EMDR; Type: EXPERIMENTAL; Interventions: Behavioral: EMDR, Behavioral: DBT | Intervention Type: BEHAVIORAL; Name: EMDR; Assigned to Arm(s): Integrated DBT-EMDR, PTSD-EMDR | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Integrated DBT-EMDR
B: Arm Label: Mindfulness training; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness training | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness training; Assigned to Arm(s): Mindfulness training
C: Arm Label: General Psychiatric Management (GPM; Gunderson & Links, 2008); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychiatric Management | Arm Label: GPM plus Motive-Oriented Therapeutic Relationship; Type: EXPERIMENTAL; Interventions: Behavioral: Psychiatric Management, Behavioral: Motive-oriented therapeutic relationship/Plan Analysis | Intervention Type: BEHAVIORAL; Name: Psychiatric Management; Assigned to Arm(s): GPM plus Motive-Oriented Therapeutic Relationship, General Psychiatric Management (GPM; Gunderson & Links, 2008) | Intervention Type: BEHAVIORAL; Name: Motive-oriented therapeutic relationship/Plan Analysis; Assigned to Arm(s): GPM plus Motive-Oriented Therapeutic Relationship
D: Intervention Type: BEHAVIORAL; Name: Cognitive Therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Supportive Therapy; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prediction and Outcome Study in PTSD and (Borderline) Personality Disorders
Brief Summary: The goal of PROSPER-B is to study effectiveness of EMDR compared to integrated DBT-EMDR in treatment-seeking, adult patients with comorbid PTSD and Borderline Personality Disorder (BPD).


Options:
A: Arm Label: PTSD-EMDR; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: EMDR | Arm Label: Integrated DBT-EMDR; Type: EXPERIMENTAL; Interventions: Behavioral: EMDR, Behavioral: DBT | Intervention Type: BEHAVIORAL; Name: EMDR; Assigned to Arm(s): Integrated DBT-EMDR, PTSD-EMDR | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Integrated DBT-EMDR
B: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up
C: Arm Label: Selegiline; Type: EXPERIMENTAL; Interventions: Drug: Selegiline | Arm Label: Placebo (for Selegiline); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (for Selegiline) | Intervention Type: DRUG; Name: Selegiline; Assigned to Arm(s): Selegiline | Intervention Type: DRUG; Name: Placebo (for Selegiline); Assigned to Arm(s): Placebo (for Selegiline)
D: Intervention Type: DRUG; Name: Depakote ER; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Immediate Effects and Safety of High-frequency Chest Wall Oscillation Compared to Airway Clearance Techniques in Non-hospitalized Infants With Acute Viral Bronchiolitis
Brief Summary: Bronchiolitis (BQ) is the acute viral infection of the tract respiratory syndrome in infants that affects the bronchioles of babies under 24 months of age. Respiratory physiotherapy (RF) appears as a treatment measure complementary in the clinical guidelines and consensus on the management of the BQ.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Chest physiotherapy | Intervention Type: PROCEDURE; Name: Chest physiotherapy; Assigned to Arm(s): Intervention
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Procedure: Chest Physiotherapy with Forced Expiratory Technique | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Nasopharyngeal Aspiration | Intervention Type: PROCEDURE; Name: Chest Physiotherapy with Forced Expiratory Technique; Assigned to Arm(s): A | Intervention Type: PROCEDURE; Name: Nasopharyngeal Aspiration; Assigned to Arm(s): B
C: Arm Label: Manual maneuvers physiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Manual maneuvers physiotherapy group | Arm Label: High frequency compression chest wall; Type: EXPERIMENTAL; Interventions: Other: High frequency compression of the chest wall group, Other: Manual maneuvers physiotherapy group | Intervention Type: OTHER; Name: High frequency compression of the chest wall group; Assigned to Arm(s): High frequency compression chest wall | Intervention Type: OTHER; Name: Manual maneuvers physiotherapy group; Assigned to Arm(s): High frequency compression chest wall, Manual maneuvers physiotherapy
D: Arm Label: Rhinopharyngeal clearance + 0.9% saline; Type: EXPERIMENTAL; Interventions: Procedure: Rhinopharyngeal clearance, Other: 0.9% saline | Arm Label: Aspiration + 0.9% saline; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Aspiration, Other: 0.9% saline | Intervention Type: PROCEDURE; Name: Rhinopharyngeal clearance; Assigned to Arm(s): Rhinopharyngeal clearance + 0.9% saline | Intervention Type: PROCEDURE; Name: Aspiration; Assigned to Arm(s): Aspiration + 0.9% saline | Intervention Type: OTHER; Name: 0.9% saline; Assigned to Arm(s): Aspiration + 0.9% saline, Rhinopharyngeal clearance + 0.9% saline

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparing the Effectiveness of Nicotine Patch With Gum Versus Nicotine Patch Alone in Smoking Cessation in Hong Kong Primary Care Clinics
Brief Summary: The prevalence of cigarette smoking has dropped to 10% in Hong Kong (HK) in 2017, however, smoking still kills 5700 persons per year. Studies suggest that abstinence rates are higher with combined NRT than single NRT, although local data on safety and benefits of combined NRT are lacking.

This is a one-year, two-arm, parallel randomized trial in 20 HK public clinics. The aim is to compare the effectiveness of combined NRT with single NRT among HK Chinese. 560 chronic smokers, who smoked ≥10 cigarettes/day for ≥ 1 year, were randomized to either intervention or usual care.

Intervention group received counseling and nicotine patch \& gum. Usual care group received counselling and nicotine patch only. Primary outcome was smoking abstinence rate at 52 weeks. Secondary outcomes included smoking abstinence rate at 4, 12, \& 26 weeks. Crude odds ratio (combined NRT vs. single NRT) and p-value were reported from logistic regression without adjustment; for trend analysis, adjusted odds ratio (AOR) and p-value were reported from Generalized Estimating Equation (GEE) (controlling for time). All AORs were adjusted for age, sex, baseline CO and clusters.


Options:
A: Arm Label: Usual group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch | Arm Label: Intervention group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine patch, Drug: Nicotine gum | Intervention Type: DRUG; Name: Nicotine patch; Assigned to Arm(s): Intervention group, Usual group | Intervention Type: DRUG; Name: Nicotine gum; Assigned to Arm(s): Intervention group
B: Arm Label: Selegiline Transdermal Patch; Type: ACTIVE_COMPARATOR; Interventions: Drug: Selegiline Transdermal Patch, Behavioral: Smoking Cessation Counseling | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Smoking Cessation Counseling | Intervention Type: DRUG; Name: Selegiline Transdermal Patch; Assigned to Arm(s): Selegiline Transdermal Patch | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BEHAVIORAL; Name: Smoking Cessation Counseling; Assigned to Arm(s): Placebo, Selegiline Transdermal Patch
C: Arm Label: Placebo Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Smoking cessation counseling, Drug: Placebo | Arm Label: Experimental: Varenicline; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smoking cessation counseling, Drug: Varenicline | Intervention Type: BEHAVIORAL; Name: Smoking cessation counseling; Assigned to Arm(s): Experimental: Varenicline, Placebo Control | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Control | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): Experimental: Varenicline
D: Intervention Type: DRUG; Name: CP-526,555 (varenicline); Assigned to Arm(s): N/A

Answer: A